Safety Profile of Anti-VEGF Agents on Retinal Pigment Epithelium Cells: In Vitro Cell Viability

被引：0
|
作者：
Bababeygy, Simon R. [1 ]
Malik, Deepika [1 ]
del Carpio, Javier Caceres [1 ]
Boyer, David S. [2 ]
Kenney, Cristina M. [1 ]
Kuppermann, Baruch [1 ]
机构：
[1] UC Irvine, Gavin Herbert Eye Inst, Ophthalmol, Irvine, CA USA
[2] Retina Vitreous Associates Med Grp, Ophthalmol, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 688; retina; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
596
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effect of VEGF and anti-VEGF compounds on retinal pigment epithelium permeability: an in vitro study
    Campa, Claudio
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (05) : 690 - 696
  • [2] Effect of VEGF and Anti-VEGF Compounds on Retinal Pigment Epithelium Permeability: An in vitro Study
    Campa, C.
    Kearns, V.
    Sheridan, C.
    Williams, R.
    Grierson, I.
    Harding, S. P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [3] Mitochondrial Membrane Potential Response of Retinal Pigment Epithelium Cells In Vitro to Anti-VEGF Agents: Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept
    Malik, Deepika
    del Carpio, Javier Caceres
    Kim, Young Gyun
    Moustafa, Mohamed Tarek Mohamed
    Thaker, Kunal
    Patel, Tej
    Bababeygy, Simon R.
    Kenney, Cristina M.
    Kuppermann, Baruch
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] Reactive Oxygen Species Levels in Human Retinal Pigment Epithelium Cells In vitro to anti-VEGF Agents: Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept
    Lin, Christine
    Malik, Deepika
    Caceres-del-Carpio, Javier
    Tarek, Mohamed
    Costa, Rodrigo Donato
    Boyer, David S.
    Kenney, Cristina M.
    Kuppermann, Baruch
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture
    Malik, Deepika
    Tarek, Mohamed
    del Carpio, Javier Caceres
    Ramirez, Claudio
    Boyer, David
    Kenney, M. Cristina
    Kuppermann, Baruch D.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 : 11 - 16
  • [6] Retinal angiomatous proliferation with associated pigment epithelium detachment. Anti-VEGF therapy
    Lommatzsch, A.
    Heimes, B.
    Gutfleisch, M.
    Spital, G.
    Dietzel, M.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2011, 108 (03): : 244 - 251
  • [7] Effects of anti-VEGF drugs on human retinal pigment epithelium under oxidative stress
    Bahrami, Bobak
    Zhu, Ling
    Zhang, Ting
    Chang, Andrew
    Gillies, Mark C.
    Shen, Weiyong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [8] Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium
    Schottler, Johann
    Randoll, Niklas
    Lucius, Ralph
    Caliebe, Amke
    Roider, Johann
    Klettner, Alexa
    EXPERIMENTAL EYE RESEARCH, 2018, 171 : 1 - 11
  • [9] Anti-Vegf therapy leads to an improvement in grade of retinal pigment epithelium alterations on single layer retinal pigment epithelium map in diabetic macular edema
    Saxena, Sandeep
    Singh, Malvika
    Chaubey, Anupriya
    Mohan, Akshay
    De, Somnath
    Kaur, Apjit
    Gilhotra, Jagjit S.
    Meyer, Carsten H.
    Akduman, Levent
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (03) : 1412 - 1417
  • [10] Effects of anti-VEGF agents on rat retinal Muller glial cells
    Guo, Bin
    Wang, Yingli
    Hui, Yannian
    Yang, Xinguang
    Fan, Qinhua
    MOLECULAR VISION, 2010, 16 (89): : 793 - 799
12345